Abstract
There is limited information on the utility of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) for the diagnosis and management of invasive mould infections (IMIs). We retrospectively evaluated patients with IMIs who underwent FDG-PET in our institution (n=13; December 1999 to April 2004), and reviewed the available literature (n=9). In 16 non-neutropenic patients with available FDG-PET imaging studies (11 from our institution), FDG-PET revealed an occult IMI site (n=3; 2 unidentified CNS involvement) and was helpful in guiding the duration of treatment (n=8). Prospective evaluation of the role of FDG-PET in the work-up and management of IMIs is needed.